100 Fifth Avenue
Waltham, MA 02451
United States
617 977 5700
https://www.apellis.com
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 702
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Cedric Francois M.D., Ph.D. | Co-Founder, President, CEO & Director | 1,2M | 2,36M | 1972 |
Dr. Pascal Deschatelets Ph.D. | Co-Founder & Chief Scientific Officer | 688,05k | 8,37M | 1970 |
Mr. Alec Machiels J.D., MBA | Co-Founder & Director | 72,5k | N/A | 1973 |
Mr. Timothy E. Sullivan | CFO & Treasurer | 716,41k | N/A | 1971 |
Mr. Adam J. Townsend | Chief Operating Officer | 701,61k | 3,2M | 1978 |
Mr. David O. Watson Esq., J.D. | General Counsel | 675,35k | N/A | 1973 |
Mr. James G. Chopas CPA | VP, Corporate Controller & Chief Accounting Officer | N/A | N/A | 1967 |
Ms. Meredith Kaya | Senior Vice President, Investor Relations & Strategic Finance | N/A | N/A | N/A |
Ms. Karen Lewis | Chief People Officer | N/A | N/A | 1973 |
Prof. Peter Hillmen M.D., Ph.D. | Head of Hematology Engagement & Member of PNH Scientific Advisory Board | N/A | N/A | N/A |
O QualityScore de governança da ISS da Apellis Pharmaceuticals, Inc. a partir de 1 de abril de 2024 é 5. As principais pontuações para Auditoria são: 4; Conselho: 6; Direitos de Acionistas: 8; Compensação: 4.